As of 3:52pm ET
| -0.02 / -0.33%|
The 2 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 7.00. The median estimate represents a +42.14% increase from the last price of 5.98.
The current consensus among 3 polled investment analysts is to Buy stock in Accretive Health Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.